YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Drug that skyrocketed 5,000% hasn't come down in price

Posted online
The drug that skyrocketed in price from $13.50 to $750 a pill has yet to come back down.

"We've agreed to lower the price of Daraprim to a price that is more affordable," Martin Shkreli, CEO of Turing Pharmaceuticals, said on ABC World News Tonight on Sept. 24. He did not specify a price or timeline.

Used by cancer and AIDS patients, the drug's price increase sparked a public outcry.

Read more from CNNMoney.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
Update cookies preferences